Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

GCC Kidney Stones Market

ID: MRFR/HC/51103-HCR
200 Pages
Nidhi Mandole
December 2024

GCC Kidney Stones Market Research Report By Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), By Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy) and By Diagnosis (Ultrasound, Intravenous Pyelography, CT scan, X-Ray, Others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

GCC Kidney Stones Market Infographic
Purchase Options

GCC Kidney Stones Market Summary

As per Market Research Future analysis, the GCC kidney stones market size was estimated at 135.0 $ Million in 2024. The GCC kidney stones market is projected to grow from 139.91 $ Million in 2025 to 200.0 $ Million by 2035, exhibiting a compound annual growth rate (CAGR) of 3.6% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The GCC kidney stones market is experiencing notable growth driven by rising incidence and technological advancements.

  • The market is witnessing a rising incidence of kidney stones, indicating a growing health concern in the region.
  • Technological advancements in treatment options are enhancing patient outcomes and driving market growth.
  • Increased public awareness and education regarding kidney stones are contributing to early diagnosis and treatment.
  • The growing prevalence of risk factors and advancements in diagnostic techniques are key drivers of the market's expansion.

Market Size & Forecast

2024 Market Size 135.0 (USD Million)
2035 Market Size 200.0 (USD Million)
CAGR (2025 - 2035) 3.64%

Major Players

Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), C.R. Bard (US), Cook Medical (US), Olympus Corporation (JP), Stryker Corporation (US), Terumo Corporation (JP), Karl Storz (DE)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

GCC Kidney Stones Market Trends

the kidney stones market is experiencing notable developments, driven by a combination of rising prevalence rates and advancements in medical technology. In the GCC region, the incidence of kidney stones appears to be increasing, influenced by factors such as dietary habits, climate, and lifestyle choices. As healthcare systems evolve, there is a growing emphasis on early diagnosis and effective treatment options. This shift is likely to enhance patient outcomes and reduce the burden on healthcare facilities. Furthermore, the integration of innovative technologies, such as minimally invasive surgical techniques and improved imaging modalities, is transforming the landscape of treatment, making it more efficient and patient-friendly. In addition to technological advancements, public awareness campaigns are gaining traction, aiming to educate individuals about prevention strategies and the importance of hydration. These initiatives may contribute to a decrease in the incidence of kidney stones over time. Moreover, the collaboration between healthcare providers and government entities is fostering a more comprehensive approach to managing this condition. As the kidney stones market continues to evolve, stakeholders must remain vigilant in addressing emerging challenges and opportunities, ensuring that patients receive optimal care and support.

Rising Incidence of Kidney Stones

The prevalence of kidney stones in the GCC region is on the rise, attributed to various lifestyle factors. Poor dietary choices, coupled with inadequate hydration, contribute to this trend. As awareness increases, healthcare providers are focusing on preventive measures to mitigate the impact of this condition.

Technological Advancements in Treatment

Innovations in medical technology are reshaping treatment options within the kidney stones market. Minimally invasive procedures and enhanced imaging techniques are becoming more common, allowing for quicker recovery times and improved patient experiences. This trend indicates a shift towards more efficient healthcare delivery.

Increased Public Awareness and Education

Public health initiatives aimed at educating the population about kidney stones are gaining momentum. These campaigns emphasize the importance of hydration and dietary modifications, potentially leading to a decrease in new cases. As awareness grows, the overall management of kidney stones may improve.

GCC Kidney Stones Market Drivers

Increasing Healthcare Expenditure

The kidney stones market is benefiting from the rising healthcare expenditure in the GCC region. Governments and private sectors are investing more in healthcare infrastructure, which includes the treatment of kidney stones. Reports indicate that healthcare spending in GCC countries is projected to reach $100 billion by 2025, reflecting a commitment to improving health services. This increase in funding allows for better access to advanced treatment options and technologies for kidney stones. As healthcare facilities expand and upgrade their services, the kidney stones market is likely to see a surge in demand for both surgical and non-surgical treatment modalities. This trend indicates a positive outlook for market growth as more patients receive timely and effective care.

Expansion of Telemedicine Services

The kidney stones market is witnessing a transformation due to the expansion of telemedicine services in the GCC region. Telehealth platforms are increasingly being utilized to provide consultations, follow-ups, and education regarding kidney stone management. This trend is particularly beneficial in remote areas where access to specialized healthcare may be limited. By leveraging technology, healthcare providers can reach a broader audience, offering guidance on prevention and treatment options for kidney stones. The convenience of telemedicine is likely to encourage more individuals to seek help for their symptoms, thereby driving demand in the kidney stones market. As telehealth continues to evolve, it may play a pivotal role in enhancing patient engagement and improving health outcomes.

Growing Prevalence of Risk Factors

The kidney stones market is experiencing growth due to the increasing prevalence of risk factors associated with stone formation. Factors such as obesity, diabetes, and dietary habits are becoming more common in the GCC region. For instance, studies indicate that the obesity rate in GCC countries has reached approximately 35%, which is a significant contributor to the rise in kidney stones. Additionally, high consumption of processed foods and low water intake exacerbate the situation. As more individuals are diagnosed with conditions that predispose them to kidney stones, the demand for treatment options and preventive measures in the kidney stones market is likely to increase. This trend suggests a potential for market expansion as healthcare providers focus on addressing these risk factors through education and intervention.

Advancements in Diagnostic Techniques

Innovations in diagnostic techniques are playing a crucial role in the kidney stones market. Enhanced imaging technologies, such as high-resolution ultrasound and CT scans, allow for more accurate detection and characterization of kidney stones. These advancements facilitate timely diagnosis and treatment, which is essential in managing the condition effectively. In the GCC region, the adoption of these technologies is on the rise, with healthcare facilities investing in state-of-the-art equipment. This shift not only improves patient outcomes but also drives the growth of the kidney stones market as more individuals seek medical attention for their symptoms. The integration of artificial intelligence in imaging analysis further enhances diagnostic accuracy, potentially leading to earlier interventions and better management of kidney stones.

Rising Awareness of Preventive Healthcare

There is a notable increase in awareness regarding preventive healthcare measures among the population in the GCC region. Educational campaigns and health initiatives are emphasizing the importance of hydration, dietary modifications, and lifestyle changes to prevent kidney stones. This growing awareness is likely to influence consumer behavior, leading to a higher demand for preventive products and services in the kidney stones market. As individuals become more proactive about their health, they may seek out supplements, dietary plans, and regular check-ups to mitigate their risk of developing kidney stones. This shift towards preventive healthcare could significantly impact the market dynamics, fostering a culture of health consciousness that benefits both patients and healthcare providers.

Market Segment Insights

By Type: Calcium Oxalate Stones (Largest) vs. Uric Acid (Fastest-Growing)

In the GCC kidney stones market, Calcium Oxalate Stones dominate the landscape, representing a considerable portion of the total cases. This segment benefits from dietary habits, with high oxalate intake being a primary contributor to its prevalence. Conversely, Uric Acid stones are increasingly recognized and gaining traction, attributed to rising obesity rates and lifestyle changes affecting uric acid levels in individuals. The growth trends within this segment show a promising trajectory for Uric Acid stones, making it the fastest-growing category due to increased awareness and advancements in treatment options. Factors driving this growth include improved diagnostic capabilities and proactive health management, particularly in regions facing lifestyle-related health challenges, enhancing the overall market landscape for kidney stones.

Calcium Oxalate Stones (Dominant) vs. Uric Acid (Emerging)

Calcium Oxalate Stones are characterized by their formation from calcium and oxalate compounds, making them the most common type of kidney stones in the GCC market. Their prevalence is closely linked to dietary habits, particularly high oxalate foods and hydration levels. On the other hand, Uric Acid stones, although less prevalent, are emerging rapidly. They form when urine is overly acidic, typically associated with diets high in purines. The rising trend of Uric Acid stones is noted as individuals become more aware of lifestyle impacts on health, leading to a focus on dietary modifications and preventive healthcare measures.

By Treatment Type: Medications (Largest) vs. Ureteroscopy (Fastest-Growing)

The GCC kidney stones market's treatment type segment is characterized by diverse options including Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithotomy. Medications hold the largest market share, primarily due to their established use in managing symptoms and aiding stone passage. Extracorporeal Shock Wave Lithotripsy follows, being a non-invasive choice that appeals to patients. Ureteroscopy and Percutaneous Nephrolithotomy, although smaller in share, are essential for treating larger stones and have their niche in specific clinical scenarios. Recent trends indicate a growing preference for Ureteroscopy, driven by advancements in technology and minimally invasive techniques. This treatment is viewed as effective and safe, leading to its classification as the fastest-growing segment. Furthermore, the increasing incidence of kidney stones in the GCC due to lifestyle changes and dietary habits is propelling demand for all these treatment options, indicating a robust growth trajectory across the segment.

Medications (Dominant) vs. Ureteroscopy (Emerging)

Medications serve as the dominant treatment option in the GCC kidney stones market, primarily focusing on pain management and aiding the expulsion of smaller stones. These drugs are often the first line of treatment, benefiting from long-standing physician familiarity and patient preference for non-invasive options. Conversely, Ureteroscopy is emerging rapidly as a vital treatment for larger stones or those not amenable to medical management. With ongoing advancements in endoscopic techniques, Ureteroscopy offers effective outcomes with reduced recovery times, making it increasingly preferred among healthcare providers. Both segments play crucial roles, yet they cater to distinct patient needs, bolstering their positions within the market.

By Diagnosis: CT Scan (Largest) vs. Ultrasound (Fastest-Growing)

In the GCC kidney stones market, the diagnosis segment is characterized by varying shares among different diagnostic methods. The CT scan is currently the largest segment, favored for its superior imaging capabilities, allowing for accurate detection and assessment of kidney stones. Ultrasound and intravenous pyelography also hold significant positions, while X-ray and other methods make up a smaller portion of the market share. Overall, the distribution reflects a preference for advanced imaging technologies that enhance diagnostic precision. Growth trends within the diagnosis segment are increasingly influenced by advancements in imaging technology and rising awareness regarding kidney stone management. The ultrasound method is emerging as a fast-growing segment due to its non-invasiveness, cost-effectiveness, and widespread availability. Additionally, increasing prevalence of kidney stone disease in the GCC region is driving the demand for accurate diagnostic solutions, particularly as healthcare systems upgrade to incorporate state-of-the-art imaging techniques for better patient outcomes.

CT Scan (Dominant) vs. Ultrasound (Emerging)

The CT scan represents the dominant diagnostic methodology in the segment, known for its high-resolution imaging that provides detailed insights into stone size and composition. This method is often preferred by healthcare professionals for its ability to quickly deliver accurate results, critical for timely treatment decision-making. On the other hand, ultrasound is rapidly emerging as a preferred option due to its cost-effectiveness and safety profile, being non-invasive without the need for radiation exposure. This combination of benefits makes ultrasound increasingly popular, especially among patients seeking less invasive yet effective diagnostic alternatives. As healthcare facilities continue to leverage both technologies, the demand for these diagnostic tools is poised to grow.

Get more detailed insights about GCC Kidney Stones Market

Key Players and Competitive Insights

The competitive dynamics within the kidney stones market are characterized by a blend of innovation, strategic partnerships, and regional expansion. Key growth drivers include the rising prevalence of kidney stones, advancements in minimally invasive surgical techniques, and increasing healthcare expenditure across the GCC. Major players such as Boston Scientific (US), Medtronic (US), and Olympus Corporation (JP) are actively shaping the landscape through their focus on technological advancements and strategic collaborations. For instance, Boston Scientific (US) emphasizes innovation in its product offerings, particularly in the development of advanced lithotripsy devices, which enhances patient outcomes and operational efficiency.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure appears moderately fragmented, with several key players holding substantial market shares. This fragmentation allows for competitive pricing strategies, yet the influence of major companies like Medtronic (US) and Johnson & Johnson (US) remains significant, as they leverage their extensive distribution networks and brand recognition to capture market share.

In October Medtronic (US) announced a strategic partnership with a leading regional healthcare provider to enhance access to its innovative kidney stone management solutions. This collaboration is poised to improve patient care by integrating advanced technologies into local healthcare systems, thereby expanding Medtronic's footprint in the GCC. Such partnerships are crucial for navigating the complex regulatory landscape and addressing the specific needs of regional markets.

In September Olympus Corporation (JP) launched a new endoscopic system designed for the treatment of kidney stones, which incorporates AI-driven imaging technology. This development not only signifies Olympus's commitment to innovation but also positions the company to capitalize on the growing demand for precision in surgical procedures. The integration of AI into medical devices is likely to enhance surgical outcomes and streamline operational processes, thereby reinforcing Olympus's competitive edge.

In November Johnson & Johnson (US) unveiled a comprehensive digital platform aimed at improving patient engagement and education regarding kidney stone prevention and treatment. This initiative reflects a broader trend towards digitalization in healthcare, where patient-centric approaches are becoming increasingly vital. By leveraging technology to enhance patient knowledge and adherence to treatment protocols, Johnson & Johnson is likely to strengthen its market position and foster long-term customer loyalty.

As of November current trends in the kidney stones market indicate a shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise to address complex healthcare challenges. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of agility and responsiveness in meeting the dynamic needs of the market.

Key Companies in the GCC Kidney Stones Market include

Industry Developments

The GCC Kidney Stones Market has seen significant developments recently, particularly with increased investments in healthcare technology aimed at improving treatment options. Companies like Siemens Healthineers and Boston Scientific are focusing on advanced imaging and surgical technologies to enhance kidney stone management. In September 2023, Medtronic announced a collaboration with local healthcare providers in the GCC to offer training and education on minimally invasive treatments for urolithiasis. Meanwhile, Stryker Corporation has been involved in expanding its product offerings in the region, with an emphasis on improving patient outcomes through innovative devices. 

In terms of mergers and acquisitions, no notable activity specific to the GCC Kidney Stones Market has been reported among the listed companies in recent months. However, the market has been positively impacted by a growing awareness of preventive care and lifestyle changes, leading to increased demand for effective treatment solutions. Over the past two years, the GCC has witnessed a surge in healthcare spending to address rising incidences of kidney stones, supported by government initiatives to enhance healthcare facilities across Saudi Arabia, UAE, and Qatar.

Future Outlook

GCC Kidney Stones Market Future Outlook

The Kidney Stones Market is projected to grow at a 3.64% CAGR from 2025 to 2035, driven by increasing prevalence, advancements in treatment technologies, and rising healthcare expenditure.

New opportunities lie in:

  • Development of telehealth platforms for remote consultations and follow-ups.
  • Investment in AI-driven diagnostic tools for early detection of kidney stones.
  • Expansion of minimally invasive surgical techniques to enhance patient recovery and satisfaction.

By 2035, the kidney stones market is expected to achieve substantial growth, driven by innovation and increased healthcare access.

Market Segmentation

GCC Kidney Stones Market Type Outlook

  • Calcium Oxalate Stones
  • Uric Acid
  • Struvite Kidney Stones
  • Cystine Stones
  • Calcium Phosphate Stones

GCC Kidney Stones Market Diagnosis Outlook

  • Ultrasound
  • Intravenous Pyelography
  • CT Scan
  • X-Ray
  • Others

GCC Kidney Stones Market Treatment Type Outlook

  • Medications
  • Extracorporeal Shock Wave Lithotripsy
  • Ureteroscopy
  • Percutaneous Nephrolithotomy

Report Scope

MARKET SIZE 2024 135.0(USD Million)
MARKET SIZE 2025 139.91(USD Million)
MARKET SIZE 2035 200.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 3.64% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), C.R. Bard (US), Cook Medical (US), Olympus Corporation (JP), Stryker Corporation (US), Terumo Corporation (JP), Karl Storz (DE)
Segments Covered Type, Treatment Type, Diagnosis
Key Market Opportunities Emergence of advanced minimally invasive treatment technologies for kidney stones.
Key Market Dynamics Rising prevalence of kidney stones drives demand for advanced treatment options and innovative technologies in the GCC region.
Countries Covered GCC
Author
Author
Author Profile
Nidhi Mandole LinkedIn
Senior Research Analyst
She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Co-Author
Co-Author Profile
Garvit Vyas LinkedIn
Analyst
Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis
Leave a Comment

FAQs

What was the overall market valuation of the GCC kidney stones market in 2024?

<p>The overall market valuation was $135.0 Million in 2024.</p>

What is the projected market valuation for the GCC kidney stones market by 2035?

<p>The projected market valuation for 2035 is $200.0 Million.</p>

What is the expected CAGR for the GCC kidney stones market during the forecast period 2025 - 2035?

<p>The expected CAGR for the market during the forecast period 2025 - 2035 is 3.64%.</p>

Which type of kidney stones had the highest valuation in 2024?

<p>In 2024, Calcium Oxalate Stones had the highest valuation, ranging from $45.0 Million to $70.0 Million.</p>

What are the key treatment types in the GCC kidney stones market?

<p>Key treatment types include Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithotomy.</p>

What was the valuation range for Extracorporeal Shock Wave Lithotripsy in 2024?

<p>The valuation range for Extracorporeal Shock Wave Lithotripsy in 2024 was $40.0 Million to $60.0 Million.</p>

Which diagnostic method had the highest valuation in 2024?

<p>CT Scan had the highest valuation in 2024, with a range of $40.0 Million to $60.0 Million.</p>

Who are the key players in the GCC kidney stones market?

<p>Key players include Boston Scientific, Medtronic, Johnson & Johnson, C.R. Bard, and others.</p>

What is the valuation range for Cystine Stones in 2024?

<p>The valuation range for Cystine Stones in 2024 was $15.0 Million to $25.0 Million.</p>

What is the projected growth trend for the GCC kidney stones market?

<p>The market is expected to grow steadily, reaching $200.0 Million by 2035, indicating a positive trend.</p>

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions